August 12, 2020 -- The U.S. National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases has awarded Celdara Medical a Small Business Innovation Research (SBIR) grant for the development of antivirals against pandemic and interpandemic influenzas.
The funding will support proof-of-concept efforts through Celdara's Pandemic Security Initiative. The initiative is a framework for public-private partnerships that incorporates science, entrepreneurship, public-sector investment, and private-sector business acumen to develop and produce treatments and vaccines that will address future pandemic threats.
Celdara's Academic Partner Network includes collaborations with 60 leading universities, and thousands of pipeline innovations from all 50 states.
Copyright © 2020 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
